Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases (Q73589339)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 2000

Language	Label	Description	Also known as
English	Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases	scientific article published on 01 March 2000

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

orthotopic liver transplantation

1 reference

based on heuristic

inferred from title

lymphoproliferative disorders

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

Francois Durand

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Didier Bouscary

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

S Zompi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Tulliez

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F Conti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

V Leblond

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Gaulard

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

P Blanche

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

D Ghandi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F Dreyfus

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Louvel

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Y Calmus

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

521-527

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Clinical characteristics of post-transplant lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Conversion from cyclosporine to FK506 for salvage of immunocompromised pediatric liver allografts. Efficacy, toxicity, and dose regimen in 23 children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Brief report: lymphoma of donor origin occurring in the porta hepatis of a transplanted liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of monoclonal immunoglobulins after liver transplantation: relationship with posttransplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980406-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(00)80406-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10735625%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73589339&oldid=1796771231"